Horizon Pharma PLC (HZNP) Financials

$116.30

$0.00 (0.00%)

As on 09-Oct-2023 09:30EDT

Market cap

$26,632 Mln

Revenue (TTM)

$3,644 Mln

P/E Ratio

61.9

P/B Ratio

5.1

Div. Yield

0 %

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18
Cash From Operating Activities	--	1,257.84	1,035.27	555.69	426.33	194.54
Cash Flow from Investing Activities	--	-134.00	-2,994.11	-464.07	-17.86	27.65
Cash from Financing Activities	--	-347.96	1,470.12	904.58	-290.45	-16.60
Net Cash Inflow / Outflow	--	775.88	-488.72	996.20	118.03	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18
Adjusted EPS ($)	1.87	2.24	2.26	1.67	2.72	-0.43
Cash EPS ($)	--	3.91	3.75	2.87	3.84	1.16
Adjusted Book Value ($)	--	21.77	19.73	17.28	10.36	6.05
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	5.40	4.37	2.39	2.02	1.12
Free Cash Flow per Share ($)	--	4.86	3.84	1.53	1.94	1.02

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18
ROCE (%)	--	7.01	8.70	9.09	17.66	-2.54
ROE (%)	8.44	10.70	12.29	12.55	35.38	-7.25
ROA (%)	4.41	5.86	7.25	7.42	13.35	-1.78
EBIT Margin (%)	14.15	17.01	16.83	22.27	9.74	0.86
Net Margin (%)	12.02	14.40	16.56	17.95	46.20	-6.14
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18
Revenue Growth (%)	-4.42	0.12	0.47	0.69	0.08	0.14
EBIT Growth (%)	-42.72	13.68	10.84	287.03	1,123.06	102.64
Net Profit Growth (%)	-38.49	-2.43	37.12	-31.98	872.40	81.93
EPS Growth (%)	-42.21	-0.01	0.35	-0.38	7.38	0.83
Book Value Growth (%)	8.41	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18
Price / Earnings	61.86	50.85	47.74	43.70	13.33	-45.89
Price / Book Value	5.10	5.23	5.46	4.23	3.49	3.23
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	24.63	23.95	29.13	20.77	21.14	15.15
Close Price ($)	102.85	113.80	107.76	73.15	36.20	19.54
High Price ($)	113.83	117.49	120.54	86.67	36.77	23.38
Low Price ($)	57.84	57.84	70.15	23.81	19.23	12.55
Market Cap ($ Cr)	26,632.12	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18
Debt to Equity	0.48	0.51	0.55	0.25	0.62	1.80
Short term debt to equity ratio	0.00	0.00	0.00	0.00	--	--
Current Ratio	4.27	3.85	3.16	3.51	2.33	2.03
Quick Ratio	4.09	3.67	2.90	3.42	2.26	1.97
Interest Coverage	7.46	7.38	6.70	8.22	1.45	0.09

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18
Debtors to sales (%)	19.69	18.64	19.61	29.98	31.44	38.48
Asset Turnover	0.37	0.41	0.44	0.42	0.30	0.29
Receivable days	--	65.88	73.16	88.67	122.70	125.84
Inventory Days	--	78.45	69.19	44.25	52.72	48.61
Payable days	--	36.90	15.59	20.30	26.12	28.09
Cash Conversion Cycle	--	107.43	126.76	112.62	149.30	146.35

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Cashflow ($ Mln)